In the News | CereSpir Inc.

CERESPIR INCORPORATED Assembles World Class Clinical Advisory Board Chaired by Professor Robert A. Hauser to Support CERESPIR’S Parkinson’s Disease Development Program for Itanapraced

by Gabrielle Morrow | Mar 26, 2019 | In the News, Press Release

NEW YORK, March 26, 2019 (PR Newswire) — CERESPIR INCORPORATED, a pharmaceutical company engaged in the discovery and development of disease-modifying therapeutics for the treatment of neurodegenerative diseases, announced the formation of an expanded Clinical...

CereSpir considers partnership and finance options to fund Phase III AD trials – CEO

by Gabrielle Morrow | Nov 5, 2014 | In the News

NOVEMBER 5, 2014 – BioPharm Insight -London,U.K. and New York, N.Y – CereSpir is in active discussions with multiple pharma companies to secure a partnership or financing to run two Phase III trials of its Alzheimer’s disease (AD) drug candidate...